Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients

Figure 5

Decision curve analysis (DCA) of the nomogram for predicting BM in patients with RCC in the training cohort (a) and the validation cohort (b). This diagnostic nomogram shows a notable positive net benefit, indicating that it has a good clinical utility in predicting estimating the risk of BM in patients with RCC.

(a)

(b)